Vivos Therapeutics (VVOS) said Friday it issued a $1.1 million convertible promissory note to V-Co Investors 2, with proceeds to be used for the acquisition of The Sleep Center of Nevada.
V-Co is affiliated with New Seneca Partners, a current investor and advisor to the company, Vivos said.
Shares of the company were up over 10% in recent trading.
Price: 2.31, Change: +0.22, Percent Change: +10.57
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.